Complementary Medicine Product Adverse Event/Safety Incident Note
Documents suspected adverse events involving dietary supplements, herbal products, and other complementary medicine products. Structured for clinical care while capturing elements needed for FDA MedWatch reporting, inclu…
Document Type
clinical note / Progress Note
Specialties
Template Preview
Date/Time: [date and time of documentation]
Author/Role: [author name, credentials, role]
Patient: [name, DOB, MRN]
Reason for Note: [Suspected adverse event / Product quality problem / Use error / Other safety concern]
Suspect Product(s)
(Repeat for each suspect product. Use "Unknown" for unavailable data rather than omitting fields.)
Product Name: [brand name as labeled]
Category: [dietary supplement / herbal / homeopathic / traditional medicine / probiotic / other]
Ingredients: [transcribe from label; include botanical names and extract ratios if listed]
Dose/Form: [strength, formulation, route]
Manufacturer/Lot: [manufacturer]; [lot/batch number]; [expiration]
Source: [retail store / online / practitioner / other]
Product Available: [Yes / No]; Photos Obtained: [Yes / No]
Exposure Details: Start [date]; Stop [date]; Dose [amount]; Frequency [schedule]; Duration [timeframe]. (Note any dose change, overdose, or rechallenge with outcome.)
Event Description
[Chronological narrative of the event] (Include baseline status before exposure, symptom onset timing relative to first dose, symptom progression, pertinent exam findings and vitals, relevant labs/imaging with dates, treatments and response, and current status. For product quality or use error, describe the issue and circumstances.)
- Concomitant medications/supplements: [list with doses] (Flag high interaction risk: anticoagulants, serotonergic agents, narrow therapeutic index drugs.)
- Medication reconciliation: [Complete / Incomplete—pending items]
Assessment
Primary Event: [suspected clinical syndrome and relationship to suspect product(s)]
Seriousness: (Select all that apply per FDA serious adverse event definitions.)
- Death: [Yes / No]
- Life-threatening: [Yes / No]
- Hospitalization (initial or prolonged): [Yes / No]
- Persistent/significant disability: [Yes / No]
- Congenital anomaly/birth defect: [Yes / No]
- Required intervention to prevent permanent impairment: [Yes / No]
- Other medically important event: [Yes / No]
Seriousness Justification: [brief factual justification]
Causality (WHO-UMC): [Certain / Probable-Likely / Possible / Unlikely / Conditional / Unassessable] — [justification addressing temporal plausibility, alternative causes, and dechallenge/rechallenge if applicable]
Differential: [key alternative explanations considered]
Plan
Actions Taken:
- Product discontinued: [Yes / No]; Date: [date]
- Poison control contacted: [Yes / No]; Reference #: [number]
- Specialist consult(s): [service and date]
- Product retained/quarantined: [Yes / No]; Location: [location]
- Label/packaging photos obtained: [Yes / No]
Counseling: [summary of discussion] (Address causality uncertainty, re-exposure risks, red-flag symptoms, and instruction to disclose supplement use to all clinicians.)
Reporting Status: [Not indicated / Considered / Completed] — (If completed: destination and tracking number. If deferred: reason and plan to revisit.)
Follow-up: [timeframe, planned monitoring, pending documentation tasks]
Want to use this template?
Copy it into your workflow, or book a demo to see Augustun draft notes like this automatically.